MAYZENT

siponimod · Novartis Pharmaceuticals Corporation

Drug timelines are a Plus or Pro feature.

22 regulatory and trial events tracked for MAYZENT, covering 2018-10-31 to 2026-07-30. Get the full timeline:

Most recent: EMA Authorised: Mayzent (siponimod fumaric acid) — Novartis Europharm Limited